Using implanted sensors for feedback control of implanted medical devices

• US 7,742,815 B2
• Filed: 09/09/2005
• Issued: 06/22/2010
• Est. Priority Date: 09/09/2005
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Salo, Rodney, Chavan, Abhijeet
• Primary Examiner(s): Layno; Carl H.
• Assistant Examiner(s): MORALES, JON ERIC C
• Application Number:
  US11/223,398
• Publication Number:
  US 20070060959A1
• Time in Patent Office: 1,747 Days
• Field of Search: 607/23, 607/44
• US Class Current: 607/23
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/36564 controlled by blood pressure
• CPC Class Codes: A61N 1/3925 Monitoring; Protecting

Abstract

A system and method for administering a therapeutic treatment to the heart, includes a pressure sensor positioned in the pulmonary artery, an implantable medical device located remotely from the sensor, and communication means for communicating pressure data from the pressure sensor to the implantable medical device. The system includes a control module operatively coupled to the implantable medical device. The control module is adapted for comparing the pulmonary arterial pressure data to a pre-programmed value, adjusting an operating parameter of the implantable medical device based on the relationship of the pulmonary arterial pressure to the pre-programmed value, and repeating this process until the relationship between the pulmonary arterial pressure data and the pre-programmed value is such that no adjustment is necessary.

Claims

1. A method of administering a cardiac rhythm management therapy to the heart, the method comprising:

sensing pulmonary arterial pressure from within the pulmonary artery with an implanted sensor;

communicating data representative of the sensed pulmonary arterial pressure from the sensor to an implanted medical device;

calculating a current pre-ejection period from the data;

comparing the current pre-ejection period to a previously calculated pre-ejection period; and

if the current pre-ejection period has changed compared to the previously calculated pre-ejection period, sending a cardiac rhythm management signal to adjust the heart rate, wherein one or more attributes of the cardiac rhythm management signal are based on a pre-programmed relationship between the current pre-ejection period and the cardiac cycle length; and

repeating the process until the relationship between the current pre-ejection period and the previously calculated pre-ejection periods is such that no adjustment in the heart rate is necessary.

2. The method of claim 1 wherein determining if the pre-ejection period is changing includes determining if the pre-ejection period is increasing or decreasing, and adjusting the heart rate includes decreasing the heart rate if the pre-ejection period is increasing and increasing the heart rate if the pre-ejection period is decreasing.

3. The method of claim 1 wherein communicating data includes communicating data with one of acoustics, radio waves or ultra sound.

4. The method of claim 1 further comprising communicating the sensed pulmonary arterial pressure data to an external device.

5. A method of administering a cardiac rhythm management therapy to the heart, the method comprising:

sensing pulmonary arterial diastolic pressure from within the pulmonary artery with an implanted sensor;

communicating data representative of the sensed pulmonary arterial pressure from the sensor to an implanted medical device;

comparing the pulmonary arterial diastolic pressure to a pre-programmed value; and

limiting increases in the heart'"'"'s pacing rate by sending a cardiac rhythm management signal to the heart to maintain pulmonary arterial diastolic pressure below the pre-programmed value; and

repeating the process until the relationship between the pulmonary arterial diastolic pressure and the pre-programmed value is such that no adjustment is necessary.

6. The method of claim 5 wherein communicating data includes communicating data with one of acoustics, radio waves or ultra sound.

7. The method of claim 5 further comprising communicating the sensed pulmonary arterial pressure data to an external device.

8. A method of administering a therapeutic treatment to the heart, the method comprising:

sensing pulmonary arterial pressure from within the pulmonary artery with an implanted sensor;

communicating data representative of the sensed pulmonary arterial pressure from the sensor to an implanted medical device;

calculating heart rate and systolic and/or pulse pressure;

determining if, based on heart rate and systolic and/or pulse pressure, (1) a ventricular arrhythmia is occurring, and (2) if so, whether the ventricular arrhythmia is potentially lethal;

administering a defibrillation shock with the implantable medical device if a ventricular arrhythmia is occurring and is considered lethal; and

administering an anti-tachy pacing protocol with the implantable medical device if a ventricular arrhythmia is occurring and is not considered lethal.

9. The method of claim 8 wherein communicating data includes communicating data with one of acoustics, radio waves or ultra sound.

10. The method of claim 8 further comprising communicating the sensed pulmonary arterial pressure data to an external device.